Zhengchuan Pharmapack(SH:603976) Shang Hai Zheng Quan Bao·2025-09-19 18:56Group 1 - The company held its 24th meeting of the 4th Board of Directors on September 19, 2025, with all 9 directors present, confirming the legality and validity of the meeting procedures [2][3][5] - The Board proposed to lower the conversion price of the "Zhengchuan Convertible Bonds" due to the stock price being below 90% of the conversion price for at least 15 out of the last 30 trading days [3][9][10] - The adjustment of the conversion price requires approval from the shareholders' meeting, and the new price must not be lower than the higher of the average stock price over the last 20 trading days or the previous trading day's average [3][11][18] Group 2 - The company issued 4.05 million convertible bonds on April 28, 2021, with a total fundraising amount of RMB 405 million, and the bonds have a maturity of 6 years [12][13] - The initial conversion price was set at RMB 46.69 per share, which has been adjusted multiple times due to equity distributions, with the latest price being RMB 45.77 per share [14][15][16] - The company plans to ensure the smooth execution of the conversion price adjustment by seeking authorization from the shareholders' meeting to handle related matters [4][19] Group 3 - The company will participate in the "2025 Investor Online Reception Day" on September 25, 2025, to enhance investor relations and governance [21][22] - Senior management will engage with investors through an online platform to address their concerns in a one-to-many format [22]